Showmenu

Sickle Cell Disease Program | UC Davis Comprehensive Cancer Center

Sickle Cell Program

UC Davis Health is committed to improving the quality of life and care of our patients living with sickle cell disease.

Sickle Cell Disease Program

Sickle Cell Program

Sickle Cell Disease

What is Sickle Cell Disease?

Sickle cell disease (SCD) is an inherited blood disorder caused by a change in the gene that helps make hemoglobin — the protein in red blood cells that carries oxygen. This change causes some red blood cells to become stiff, sticky, and “sickle” shaped instead of soft and round.

Sickle shaped cells can block small blood vessels, reducing blood flow and oxygen. This can cause pain, organ damage and other serious health problems.

Who Is Affected?

SCD is the most common genetic disorder in the United States, affecting about 100,000 people. A person develops SCD only if they inherit the sickle cell gene from both biological parents.

If someone inherits the gene from one parent, they have sickle cell trait (SCT). People with SCT usually have no symptoms but can pass the gene to their children.

If someone inherits the gene from one parent, they have sickle cell trait (SCT). People with SCT usually have no symptoms but can pass the gene to their children.

Certain groups are more impacted:

  • About 1 in 13 Black/African American babies are born with SCT.
  • About 1 in 163,000 Latino babies are born with SCT.

Living With Sickle Cell Disease

Years ago, people with SCD often did not live into adulthood. Thanks to better care — including preventive antibiotics, vaccines and medications such as hydroxyurea — many people with SCD now live well into adulthood and older age.

Ongoing research at UC Davis and at other institutions is improving treatments and offering new hope for those living with the disease.

For more information, go to the Centers for Disease Control’s “About Sickle Cell Disease” to learn about the disease.

People with sickle cell disease receive a variant of care services including:

  • Infusion services (port-a-cath care, IV hydration, blood transfusions, partial manual exchange, iron chelation, outpatient pain management, crizanlizumab) and apheresis exchange (blood filtering)
  • Gene therapy clinical trials
  • Therapeutic services with a licensed clinical social worker, including psychosocial assessments, crisis intervention, case management and brief supportive counseling

Patient Services

Coping with sickle cell disease can be challenging. At UC Davis Health, patients have access to a comprehensive care team that provides coordinated, multidisciplinary care. This includes regular visits with your primary care provider, specialty care along with ongoing lab testing and monitoring.

Coordinated Specialty Care

Patients may see an ophthalmologist for annual eye exams due to increased risk of retinal damage, as well as specialists in pulmonology, orthopedics and dermatology. A team-based approach across UC Davis Health helps improve outcomes and overall quality of life for people living with sickle cell disease.